Stockholm University announce a sponsored research agreement with Ipsen
Stockholm University announces that it has initiated a research collaboration on structural studies of novel engineered botulinum toxins with Ipsen, a global specialty driven pharmaceutical group. Under the terms of the agreement, Ipsen will fund research in the laboratory of Associate Prof. Pål Stenmark at the Department of Biochemistry and Biophysics, Stockholm University, with a focus on structural biology, protein design and the biophysical properties of novel engineered botulinum toxins.
Last updated:
August 19, 2016
Page editor:
Alexander Tuuling
Source: DBB
